(Q44210387)

30 November 2017

Lipid and non-lipid cardiovascular risk factors in postmenopausal type 2 diabetic women with and without coronary heart disease (English)

1 reference

cardiovascular disease in women

30 November 2017

0 references

author name string

G T Russo

1

1 reference

30 November 2017

A Giandalia

2

1 reference

30 November 2017

E L Romeo

3

1 reference

30 November 2017

M Marotta

4

1 reference

30 November 2017

A Alibrandi

5

1 reference

30 November 2017

C De Francesco

6

1 reference

30 November 2017

K V Horvath

7

1 reference

30 November 2017

B Asztalos

8

1 reference

30 November 2017

D Cucinotta

9

1 reference

30 November 2017

9 January 2014

1 reference

Journal of Endocrinological Investigation

30 November 2017

1 reference

30 November 2017

37

1 reference

30 November 2017

3

1 reference

30 November 2017

261-268

1 reference

https://scigraph.springernature.com/pub.10.1007/s40618-013-0023-z

30 November 2017

0 references

cites work

Ischemic heart disease in women and the role of hormone therapy

1 reference

https://api.crossref.org/works/10.1007%2FS40618-013-0023-Z

Diabetes and Glucose Tolerance as Risk Factors for Cardiovascular Disease: The Framingham Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-013-0023-Z

Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-013-0023-Z

Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-013-0023-Z

Cardiovascular risk in women with diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-013-0023-Z

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-013-0023-Z

Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-013-0023-Z

The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in patients with dyslipidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-013-0023-Z

Diabetic dyslipidaemia: from basic research to clinical practice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-013-0023-Z

Inflammation and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-013-0023-Z

C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-013-0023-Z

Low-grade systemic inflammation and the development of type 2 diabetes: the atherosclerosis risk in communities study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-013-0023-Z

C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-013-0023-Z

High-sensitivity C-reactive protein as cardiovascular risk marker in patients with diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-013-0023-Z

Mild hyperhomocysteinemia, C677T polymorphism on methylenetetrahydrofolate reductase gene and the risk of macroangiopathy in type 2 diabetes: a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-013-0023-Z

Effects of lowering homocysteine levels with B vitamins on cardiovascular disease, cancer, and cause-specific mortality: Meta-analysis of 8 randomized trials involving 37 485 individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-013-0023-Z

Women show worse control of type 2 diabetes and cardiovascular disease risk factors than men: results from the MIND.IT Study Group of the Italian Society of Diabetology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-013-0023-Z

Diverging association of reduced glomerular filtration rate and albuminuria with coronary and noncoronary events in patients with type 2 diabetes: the renal insufficiency and cardiovascular events (RIACE) Italian multicenter study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-013-0023-Z

Menopause modulates homocysteine levels in diabetic and non-diabetic women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-013-0023-Z

Prediction of creatinine clearance from serum creatinine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-013-0023-Z

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-013-0023-Z

A novel and simple method for quantification of small, dense LDL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-013-0023-Z

Gender medicine: a task for the third millennium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-013-0023-Z

Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-013-0023-Z

MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-013-0023-Z

Influence of menopause and cholesteryl ester transfer protein (CETP) TaqIB polymorphism on lipid profile and HDL subpopulations distribution in women with and without type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-013-0023-Z

Small dense LDL: An emerging risk factor for cardiovascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-013-0023-Z

TRL, IDL, and LDL apolipoprotein B-100 and HDL apolipoprotein A-I kinetics as a function of age and menopausal status

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-013-0023-Z

Small dense LDL cholesterol and coronary heart disease: results from the Framingham Offspring Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-013-0023-Z

Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-013-0023-Z

Sex differences in hypertension-related renal and cardiovascular diseases in Italy: the I-DEMAND study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-013-0023-Z

Gender difference in the impact of type 2 diabetes on coronary heart disease risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-013-0023-Z

Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-013-0023-Z

Insulin and risk of cardiovascular disease: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-013-0023-Z

Basal insulin and cardiovascular and other outcomes in dysglycemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-013-0023-Z

Rosuvastatin, inflammation, C-reactive protein, JUPITER, and primary prevention of cardiovascular disease--a perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-013-0023-Z

C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-013-0023-Z

Increased levels of soluble vascular cell adhesion molecule 1 are associated with risk of cardiovascular mortality in type 2 diabetes: the Hoorn study

21 January 2018

2 references

https://api.crossref.org/works/10.1007%2FS40618-013-0023-Z

21 January 2018

12 December 2020

Standards of medical care in diabetes--2012

1 reference

12 December 2020

Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report

1 reference

12 December 2020

Incidence of coronary heart disease in type 2 diabetic men and women: impact of microvascular complications, treatment, and geographic location

1 reference

12 December 2020

Characterization of low-density lipoprotein subclasses: methodologic approaches and clinical relevance.

1 reference

12 December 2020

Sex disparities in the quality of diabetes care: biological and cultural factors may play a different role for different outcomes: a cross-sectional observational study from the AMD Annals initiative

1 reference

12 December 2020

Cholesterol in remnant-like lipoproteins in human serum using monoclonal anti apo B-100 and anti apo A-I immunoaffinity mixed gels

1 reference

12 December 2020

The small, dense LDL phenotype and the risk of coronary heart disease: epidemiology, patho-physiology and therapeutic aspects.

1 reference

12 December 2020

Hyperhomocysteinemia and cardiovascular risk in diabetes mellitus

1 reference

12 December 2020

10.1007/S40618-013-0023-Z

Identifiers

DOI

1 reference

30 November 2017

1 reference